Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 244

Similar articles for PubMed (Select 22139615)

1.

Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.

Chhablani J, Jalali S.

Eur J Ophthalmol. 2012 Jul-Aug;22(4):677-9. doi: 10.5301/ejo.5000095.

PMID:
22139615
2.

Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.

Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F.

Retina. 2011 Oct;31(9):1841-7. doi: 10.1097/IAE.0b013e31821800a4.

PMID:
21775926
3.

Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab.

Cennamo G, Cesarano I, Vecchio EC, Reibaldi M, de Crecchio G.

J Ocul Pharmacol Ther. 2012 Dec;28(6):643-6. doi: 10.1089/jop.2011.0250. Epub 2012 Jun 28.

PMID:
22742532
4.

Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.

El Matri L, Kort F, Bouraoui R, Karim B, Chebil A, Chaker N.

Acta Ophthalmol. 2011 Nov;89(7):641-6. doi: 10.1111/j.1755-3768.2009.01836.x. Epub 2010 Dec 14.

5.

Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study.

Arevalo JF, Sánchez JG, Wu L, Berrocal MH, Alezzandrini AA, Restrepo N, Maia M, Farah ME, Brito M, Díaz-Llopis M, Rodríguez FJ, Reategui G, Iturralde-Iraola J, Udaondo-Mirete P; Pan-American Collaborative Retina Study Group.

Ophthalmology. 2010 Oct;117(10):1974-81, 1981.e1. doi: 10.1016/j.ophtha.2010.01.056. Epub 2010 May 31.

PMID:
20569989
6.

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):779-84. doi: 10.1007/s00417-010-1302-4. Epub 2010 Feb 19.

PMID:
20169357
7.

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

Acta Ophthalmol. 2009 Jun;87(4):404-7. doi: 10.1111/j.1755-3768.2008.01262.x. Epub 2008 Sep 8.

8.

Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.

Mimoun G, Caillaux V, Querques G, Rothschild PR, Puche N, Souied EH.

Retina. 2013 Mar;33(3):513-21. doi: 10.1097/IAE.0b013e3182753adb.

PMID:
23400081
9.

[Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].

Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C.

J Fr Ophtalmol. 2011 Jun;34(6):376-81. doi: 10.1016/j.jfo.2011.03.004. Epub 2011 May 7. French.

10.

Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial.

Zhang H, Liu ZL, Sun P, Gu F.

Am J Ophthalmol. 2012 Feb;153(2):300-306.e1. doi: 10.1016/j.ajo.2011.07.019. Epub 2011 Oct 6.

PMID:
21982109
11.

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.

12.

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

Retina. 2008 Nov-Dec;28(10):1387-94. doi: 10.1097/IAE.0b013e3181884ff4.

PMID:
18827735
13.

Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.

De Benedetto U, Battaglia Parodi M, Knutsson KA, Librando A, Bandello F, Lanzetta P, Iacono P.

J Ocul Pharmacol Ther. 2012 Oct;28(5):550-2. Epub 2012 May 3.

PMID:
22554238
14.

Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up.

Ruiz-Moreno O, Calvo P, Ferrández B, Torrón C.

Acta Ophthalmol. 2012 Nov;90(7):e574-5. doi: 10.1111/j.1755-3768.2011.02363.x. Epub 2012 Feb 17. No abstract available.

15.

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.

PMID:
17420694
16.

Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.

Am J Ophthalmol. 2006 Jul;142(1):1-9.

PMID:
16815245
17.

[Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].

Perol J, Wolff B, Sahel JA, Le Mer Y.

J Fr Ophtalmol. 2011 May;34(5):281-6. doi: 10.1016/j.jfo.2010.11.021. Epub 2011 Apr 20. French.

18.

Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results.

Peiretti E, Vinci M, Fossarello M.

Can J Ophthalmol. 2012 Feb;47(1):28-33. doi: 10.1016/j.jcjo.2011.12.009.

PMID:
22333848
19.

Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.

Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, Bonomo PP.

Ophthalmic Surg Lasers Imaging. 2010 Sep-Oct;41(5):546-9. doi: 10.3928/15428877-20100726-04. Epub 2010 Jul 29.

PMID:
20795575
20.

Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.

Tran TH, Fardeau C, Terrada C, Ducos De Lahitte G, Bodaghi B, Lehoang P.

Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1685-92. doi: 10.1007/s00417-008-0906-4. Epub 2008 Aug 6.

PMID:
18682970
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk